122 related articles for article (PubMed ID: 9169985)
1. Pharmacokinetics of mitomycin C (MMC) after intraperitoneal administration of MMC-gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice.
Fujita T; Tamura T; Yamada H; Yamamoto A; Muranishi S
J Drug Target; 1997; 4(5):289-96. PubMed ID: 9169985
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of antitumor and toxic side effects of mitomycin C-estradiol conjugates.
Ishiki N; Onishi H; Machida Y
Int J Pharm; 2004 Jul; 279(1-2):81-93. PubMed ID: 15234797
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic study of intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles].
Liang H; Tang HW; Hao XS; Sun H; Li W
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):412-5. PubMed ID: 16188126
[TBL] [Abstract][Full Text] [Related]
4. In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
Sato M; Onishi H; Takahara J; Machida Y; Nagai T
Biol Pharm Bull; 1996 Sep; 19(9):1170-7. PubMed ID: 8889036
[TBL] [Abstract][Full Text] [Related]
5. Intracavitary administration: pharmacokinetic advantages of macromolecular anticancer agents against peritoneal and pleural carcinomatoses.
Kimura M; Konno T; Miyamoto Y; Kojima Y; Maeda H
Anticancer Res; 1998; 18(4A):2547-50. PubMed ID: 9703908
[TBL] [Abstract][Full Text] [Related]
6. [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma].
Qu QL; Zhang YG; Yang LZ; Sun L
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):257-60. PubMed ID: 16875622
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor effect of MMC mixed in Beriplast P].
Yano K; Matsuoka H; Baba H; Konoe S; Seo Y; Saito T; Tomoda H
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1629-31. PubMed ID: 7574778
[TBL] [Abstract][Full Text] [Related]
8. Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice.
Kodama N; Murata Y; Asakawa A; Inui A; Hayashi M; Sakai N; Nanba H
Nutrition; 2005 May; 21(5):624-9. PubMed ID: 15850970
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
Fujimoto K; Oka T; Morimoto M
Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C.
Sugarbaker PH; Stuart OA; Carmignani CP
Cancer Chemother Pharmacol; 2006 May; 57(5):703-8. PubMed ID: 16096789
[TBL] [Abstract][Full Text] [Related]
11. In vivo properties of the conjugates of mitomycin C with estradiol benzoate and estradiol: pharmacokinetics and antitumor characteristics against P388 leukemia and sarcoma 180.
Ishiki N; Onishi H; Machida Y
Biol Pharm Bull; 1998 Nov; 21(11):1180-6. PubMed ID: 9853409
[TBL] [Abstract][Full Text] [Related]
12. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development.
Phillips RM; Burger AM; Loadman PM; Jarrett CM; Swaine DJ; Fiebig HH
Cancer Res; 2000 Nov; 60(22):6384-90. PubMed ID: 11103802
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic, angiographic, and histologic comparison of catheter-directed chemoembolization versus systemic chemotherapy in a canine model.
Zhan X; Thorpe PE; Agrawal DK; Luo HC; Yan X
Can J Physiol Pharmacol; 1996 Oct; 74(10):1117-25. PubMed ID: 9022831
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheres.
Rump AF; Woschée U; Theisohn M; Fischbach R; Heindel W; Lackner K; Klaus W
Eur J Clin Pharmacol; 2002 Oct; 58(7):459-65. PubMed ID: 12389068
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y
Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076
[TBL] [Abstract][Full Text] [Related]
16. In vivo anti-tumor activities of gelatin.
Inamura Y; Koide T; Kojima T; Nagata H; Ito N; Suzumura K; Hashimoto Y
Exp Oncol; 2009 Sep; 31(3):144-8. PubMed ID: 19783967
[TBL] [Abstract][Full Text] [Related]
17. [Potentiation of the therapeutic effect of chemotherapy and hyperthermia on experimental tumor and reduction of immunotoxicity of mitomycin C by juzen-taiho-toh, a Chinese herbal medicine].
Komiyama K; Zhibo Y; Umezawa I
Gan To Kagaku Ryoho; 1989 Feb; 16(2):251-7. PubMed ID: 2493224
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of pluronic F-127 gel containing mitomycin C on sarcoma-180 ascites tumor in mice.
Miyazaki S; Ohkawa Y; Takada M; Attwood D
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2224-6. PubMed ID: 1423788
[TBL] [Abstract][Full Text] [Related]
19. The antitumor effect induced by local injections with interleukin-2 is diminished by combing with a local injection with mitomycin C.
Li T; Harada M; Tamada K; Abe K; Ito O; Takenoyama M; Nomoto K
Immunopharmacol Immunotoxicol; 1996 Nov; 18(4):497-509. PubMed ID: 8933166
[TBL] [Abstract][Full Text] [Related]
20. Polymeric prodrugs of mitomycin C designed for tumour tropism and sustained activation.
Seymour LW; Soyez H; De Marre A; Shoaibi MA; Schacht EH
Anticancer Drug Des; 1996 Jul; 11(5):351-65. PubMed ID: 8765529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
